Scott Gottlieb, MD, discusses the real-world outcomes of tildrakizumab for moderate to severe plaque psoriasis.

Can what you eat help calm psoriasis, a chronic inflammatory disease that affects the skin? It's identified by the ...

Psoriasis is an inflammatory condition that speeds up the life cycle of skin cells, causing red, scaly patches that can be itchy, painful, or cracked. Managing psoriasis can be tricky: There are oral, ...

Consuming a greater proportion of nutrients from plant sources may aid management of psoriasis symptoms, according to a new study.

In this video interview, James Song, MD, FAAD, Co-CMO spoke about his presentation from Maui Derm 2026 on what’s new with current therapies for psoriasis.

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

A study suggests that bimekizumab does not increase the risk for depression or suicidal ideation compared with IL-23 inhibitors in adults with psoriasis.

Ginger has been used for centuries as a natural remedy for digestive issues and inflammation. Today, research suggests this ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful ...